An Innovative New Cancer Therapy Hijacks Bacteria to Fight Tumors

zq9xmldag6mehi5p7e08Researchers from South Korea have engineered a strain of bacteria that infiltrates tumors and fools the body’s immune system into attacking cancer cells. In experiments, the modified bacteria worked to reduce cancer in mice, raising hope for human trials.

In a study published today in Science Translational Medicine, a research team led by biologists Joon Haeng Rhee and Jung-Joon Min from Chonnam National University in South Korea describe a new immunotherapy in which a bioengineered strain of Salmonella is converted into a biological version of the fabled Trojan Horse. Once inside an unsuspecting tumor, the modified bacteria transmits a signal that triggers nearby immune cells into launching an attack on the malignant cells.

By George Dvorsky | Gizmodo

Image Credit: NIH

READ MORE

About Peter Coffaro 1134 Articles

A growth-driven and strategic executive, Peter Coffaro commands more than 20 years of progressive management success within the medical device industry. As a District Sales Manager for Stryker Orthopaedics, Peter was responsible for managing and directing a regional sales force to achieve sales and profit goals within the Rocky Mountain region. Previously, he was the Director of Sales & Marketing for Amp Orthopedics. In this role, Peter was responsible for planning, developing, and leading all sales and marketing initiatives. Peter is a former orthopedic distributor in the Pacific Northwest. He has also worked with DePuy Orthopaedics as well as Zimmer, and held positions in sales, sales training, and sales management. Peter has an extensive background in organizational development, business development, sales management, negotiating and P&L management. Peter holds a B.S. degree in Biology from Northern Illinois University.

Be the first to comment

Leave a Reply

Your email address will not be published.


*